21:19 , Mar 22, 2019 |  BC Extra  |  Company News

Management tracks: Mirum, Novocure

Mirum said Mike Grey has stepped down as CEO but will remain executive chairman. Mirum Pharmaceuticals Inc. (San Francisco, Calif.) promoted President Chris Peetz to CEO. Peetz is also a director. Mirum launched in 2018...
19:15 , Feb 22, 2019 |  BC Week In Review  |  Financial News

Merck KGaA spinout Calypso raises first tranche of €20M series A

Calypso Biotech B.V. (Amsterdam, the Netherlands) closed the first tranche of a €20 million ($22.6 million) series A round Feb. 20, with enough funding to begin clinical studies of its lead candidate to treat eosinophilic...
00:20 , Feb 21, 2019 |  BC Extra  |  Financial News

Merck KGaA spinout Calypso raises first tranche of €20M series A

Calypso Biotech B.V. (Amsterdam, the Netherlands) closed the first tranche of a €20 million ($22.6 million) series A round Wednesday, with enough funding to begin clinical studies of its lead candidate to treat eosinophilic esophagitis....
20:28 , Feb 6, 2019 |  BC Extra  |  Company News

Management tracks: Astellas, Blueprint

Astellas Pharma Inc. (Tokyo:4503) said President of Pharmaceutical Technology Mitsunori Matsuda and President of Asia & Oceania Business Masatoshi Kuroda will resign, effective June 18. Hideki Shima will succeed Matsuda. Cancer and rare diseases company...
22:54 , Dec 20, 2018 |  BC Extra  |  Company News

Merck KGaA puts CAR T development in Intrexon's hands

Merck KGaA (Xetra:MRK) has become the latest pharma to realize early stage CAR T technologies may be best in the hands of smaller companies after transferring to Intrexon Corp. (NYSE:XON) development rights for partnered CAR...
20:48 , Oct 23, 2018 |  BC Extra  |  Company News

Management tracks: Celgene, Seres, AC Immune

Celgene Corp. (NASDAQ:CELG) hired Alise Reicin as president of global clinical development, a newly created position. She was SVP and head of global clinical development in R&D at the EMD Serono business of Merck KGaA...
21:16 , Aug 31, 2018 |  BC Extra  |  Company News

Management tracks: Medigene, Merck KGaA

Medigene AG (Xetra:MDG1) said CFO Thomas Taapken has resigned. Medigene is seeking a successor. Taapken, who joined the cancer immunotherapy company in January 2017, will continue to advise Medigene as a consultant through the end...
00:06 , Jun 28, 2018 |  BC Extra  |  Company News

Management tracks: Arrakis, Astellas

Arrakis Therapeutics Inc. (Waltham, Mass.) founder and CSO Russ Petter is transitioning to Jennifer Petter. The news was announced in a blog post by Chairman and CEO Michael Gilman. "The support for this transition at...
17:35 , Mar 23, 2018 |  BC Week In Review  |  Company News

Lundbeck snags PD play Prexton

H. Lundbeck A/S (CSE:LUN) will acquire Prexton Therapeutics B.V. (Oss, the Netherlands) for €100 million ($123.4 million) up front. Shareholders in the neurology company will also be eligible for up to €805 million ($993.2 million)...
10:47 , Mar 16, 2018 |  BC Extra  |  Company News

Lundbeck snags PD play Prexton

H. Lundbeck A/S (CSE:LUN) will acquire Prexton Therapeutics B.V. (Oss, the Netherlands) for €100 million ($123.4 million) up front. Shareholders in the neurology company will also be eligible for up to €805 million ($993.2 million)...